Exelixis (EXEL) EBT (2010 - 2026)
Exelixis (EXEL) reported EBT of $262.68 million for Q2 2027, up 14.0% from $230.42 million a year earlier but down 1.9% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) EBT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jul 3, 2026, Exelixis' EBT came in at $1.04 billion, up 33.5% year-over-year; for FY2026, it was $941.21 million, up 38.1% from FY2025.
- EBT has a five-year compound annual growth rate of 26.2% (FY2021 to FY2026).
- By year, EBT came in at $681.64 million in FY2025, $257.52 million in FY2023 (+9.9%) and $234.35 million in FY2022 (-20.3%).
- Five-year quarterly EBT spans a low of $49.27 million in Q1 2025 and a high of $292.85 million in Q2 2025.
- Year over year, EBT has now increased in each of the last four quarters, with growth averaging 73.4% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2027 came in at $267.69 million (Q1 2027), $252.69 million (Q4 2026) and $252.41 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 262.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 262.68 Mn |
| Apr 3, 2026 | 267.69 Mn |
| Jan 2, 2026 | 252.69 Mn |
| Oct 3, 2025 | 252.41 Mn |
| Jul 4, 2025 | 230.42 Mn |
| Apr 4, 2025 | 205.69 Mn |
| Jan 3, 2025 | 184.77 Mn |
| Sep 27, 2024 | 154.76 Mn |
| Jun 28, 2024 | 292.85 Mn |
| Mar 29, 2024 | 49.27 Mn |
| Dec 29, 2023 | 103.04 Mn |
| Sep 29, 2023 | 5.82 Mn |
| Jun 30, 2023 | 100.39 Mn |
| Mar 31, 2023 | 48.28 Mn |
| Dec 30, 2022 | -31.43 Mn |
| Sep 30, 2022 | 92.04 Mn |
| Jul 1, 2022 | 88.51 Mn |
| Apr 1, 2022 | 85.23 Mn |
| Dec 31, 2021 | 118.02 Mn |
| Oct 1, 2021 | 53.26 Mn |
API Access
Exelixis EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();